drugset / Trial / NCT03143010

Comparison of Different Doses of Dexmedetomidine Effect in the Duration of Spinal Anesthesia

NCT03143010 ↗

Unknown 200 enrolled Cairo University
RandomizedParallel-groupDouble-blindSupportive care

Summary

Small doses of dexmedetomidine1.5,3, 5µg used in combination with bupivacaine, in humans for spinal anesthesia has been shown to produce a more rapid onset of motor block, and a longer duration of motor and sensory block with preserved hemodynamic stability and lack of sedation.

Timeline

Start
2017-05-07
Primary completion
2017-07-30
Completion
2017-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1.5 ug Intrathecal
Subject Dexmedetomidine Other / unclassified 3 ug Intrathecal
Subject Dexmedetomidine Other / unclassified 5 ug Intrathecal

Indications

No indication recorded.